Cantabio Pharmaceuticals, Purdue Research Foundation sign cooperation agreement to investigate targeting of DJ-1 protein for treating Parkinson's disease, other neurodegenerative diseases July 11, 2016
Cantabio Pharmaceuticals and University of Antioquia Collaborate to Research Company’s Therapeutic Candidates Targeting DJ-1 Protein to Treat Parkinson’s Disease June 16, 2016
Cantabio Pharmaceuticals Announces the Development of Small Molecule Chaperones of the Abeta Peptide for the Treatment of Alzheimer's Disease in Collaboration with NovAliX April 12, 2016
CANTABio and Gardedam Therapeutics complete Merger to Tackle Development of Novel Therapeutics for Alzheimer's and Parkinson's Disease December 21, 2015